Nicox Extends Existing Flexible Equity Financing

What are the covenants or terms attached to the extended financing that could affect future financing flexibility? How does this financing move compare to recent financing activities of NICX's direct competitors? Will the extended financing provide sufficient runway for NICX's upcoming R&D and commercial milestones? How will the extension of the flexible equity financing affect NICX's liquidity and capital structure? What are the potential dilution effects for existing shareholders from the extended equity financing? What is the expected impact of this financing extension on NICX's short-term and long-term stock price performance? How might this financing extension influence market perception of NICX's financial health and risk profile?